Logo Logo

Publications by Laubender, Rüdiger P.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 71.

Journal article

Haas, Michael; Ormanns, Steffen; Bächmann, Sibylle; Remold, Anna; Krüger, Stephan; Westphalen, Christoph B.; Siveke, Jens T.; Wenzel, Patrick; Schlitter, Anna Melissa; Esposito, Irene; Quietzsch, Detlef; Clemens, Michael R.; Kettner, Erika; Laubender, Rüdiger P.; Jung, Andreas; Kirchner, Thomas; Böck, Stefan; Heinemann, Volker (2017): Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer. In: British Journal of Cancer, Vol. 116, No. 11: pp. 1462-1469

Siebermair, Johannes; Sinner, Moritz F.; Beckmann, Britt-Maria; Laubender, Rüdiger P.; Martens, Eimo; Sattler, Stefan; Fichtner, Stephanie; Estner, Heidi L.; Kääb, Stefan; Wakili, Reza (2016): Early repolarization pattern is the strongest predictor of arrhythmia recurrence in patients with idiopathic ventricular fibrillation: results from a single centre long-term follow-up over 20 years. In: Europace, Vol. 18, No. 5: pp. 718-725

Michl, M.; Thurmaier, J.; Schubert-Fritschle, Gabriele; Wiedemann, Max; Laubender, Rüdiger P.; Nussler, N. C.; Ruppert, R.; Kleeff, J.; Schepp, W.; Reuter, C.; Lohe, F.; Karthaus, M.; Neumann, J.; Kirchner, T.; Engel, Jutta; Heinemann, V. (2015): Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors. In: Clinical Colorectal Cancer, Vol. 14, No. 4: pp. 281-290

Gamba, Sebastian; Camaj, Peter; Heinemann, Volker; Laubender, Rüdiger P.; Wang, Yan; Zhao, Yue; Stintzing, Sebastian; Giessen, Clemens; Boeck, Stefan; Haertl, Christoph; Bruns, Christiane J.; Modest, Dominik P. (2015): Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib. In: Anti-Cancer Drugs, Vol. 26, No. 4: pp. 371-378 [PDF, 251kB]

Ormanns, Steffen; Siveke, Jens T.; Heinemann, Volker; Haas, Michael; Sipos, Bence; Schlitter, Anna Melissa; Esposito, Irene; Jung, Andreas; Laubender, Rüdiger P.; Kruger, Stephan; Vehling-Kaiser, Ursula; Winkelmann, Cornelia; Fischer von Weikersthal, Ludwig; Clemens, Michael R.; Gauler, Thomas C.; Märten, Angela; Geissler, Michael; Greten, Tim F.; Kirchner, Thomas; Boeck, Stefan: pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104. In: BMC Cancer 2014, 14:624 [PDF, 408kB]

Laubender, Rüdiger P.; Bender, R. (2014): A note on calculating asymptotic confidence intervals for the adjusted risk difference and number needed to treat in the Cox regression model. In: Statistics in Medicine, Vol. 33, No. 5: pp. 198-810

Michl, M.; Haug, A. R.; Jakobs, T. F.; Paprottka, P.; Hoffmann, R. T.; Bartenstein, P.; Boeck, S.; Haas, M.; Laubender, Rüdiger P.; Heinemann, V. (2014): Radioembolization with Yttrium-90 Microspheres (SIRT) in Pancreatic Cancer Patients with Liver Metastases: Efficacy, Safety and Prognostic Factors. In: Oncology, Vol. 86, No. 1: pp. 24-32

Modest, Dominik P.; Schulz, Christoph; Fischer von Weikersthal, Ludwig; Quietzsch, Detlef; Einem, J. C. von; Schalhorn, Andreas; Vehling-Kaiser, Ursula; Laubender, Rüdiger P.; Giessen, Clemens; Stintzing, Sebastian; Heinemann, Volker (2014): Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut): analysis of the FIRE1-trial (FuFIRI or mIROX as first-line treatment). In: Anticancer Drugs, Vol. 25, No. 2: pp. 212-218 [PDF, 442kB]

Thieme, U.; Schelling, Gustav; Hauer, D.; Greif, R.; Dame, T.; Laubender, Rüdiger P.; Bernhard, W.; Thieme, D.; Campolongo, P.; Theiler, L. (2014): Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans. In: Drug Testing and Analysis, Vol. 6, No. 1-2: pp. 17-23

Tillack, Cornelia; Ehmann, Laura Maximiliane; Friedrich, Matthias; Laubender, Rüdiger P.; Papay, Pavol; Vogelsang, Harald; Stallhofer, Johannes; Beigel, Florian; Bedynek, Andrea; Wetzke, Martin; Maier, Harald; Koburger, Maria; Wagner, Johanna; Glas, Jürgen; Diegelmann, Julia; Koglin, Sarah; Dombrowski, Yvonne; Schauber, Jürgen; Wollenberg, Andreas; Brand, Stephan (2014): Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-gamma-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment. In: Gut, Vol. 63, No. 4: pp. 567-577

Boeck, S.; Ormanns, S.; Haas, M.; Bachmann, S.; Laubender, Rüdiger P.; Siveke, J. T.; Jung, A.; Kirchner, T.; Heinemann, V. (2014): Translational research in pancreatic cancer: KRAS and beyond. In: Pancreas, Vol. 43, No. 1: pp. 150-152

Lee, Serene M. L.; Schelcher, Celine; Laubender, Rüdiger P.; Fröse, Natalja; Thasler, Reinhard M. K.; Schiergens, Tobias S.; Mansmann, Ulrich; Thasler, Wolfgang E. (2014): An Algorithm that Predicts the Viability and the Yield of Human Hepatocytes Isolated from Remnant Liver Pieces Obtained from Liver Resections.
In: PLOS ONE 9(10), e107567 [PDF, 4MB]

Piotrowski, Katja; Becker, Melanie; Zugwurst, Julia; Biller-Friedmann, Ingeborg; Spoettl, Gerald; Greif, Martin; Leber, Alexander W.; Becker, Alexander; Laubender, Rüdiger P.; Lebherz, Corinna; Göke, Burkhard; Marx, Nikolaus; Parhofer, Klaus G.; Lehrke, Michael: Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans. In: Cardiovascular Diabetology 2013, 12:117 [PDF, 178kB]

Pomschar, A.; Koerte, I.; Lee, S.; Laubender, Rüdiger P.; Straube, A.; Heinen, Florian; Ertl-Wagner, Birgit; Alperin, N. (2013): Correction: MRI Evidence for Altered Venous Drainage and Intracranial Compliance in Mild Traumatic Brain Injury.
In: PLOS ONE 8(12) [PDF, 1MB]

Pomschar, A.; Koerte, I.; Lee, S.; Laubender, Rüdiger P.; Straube, A.; Heinen, Florian; Ertl-Wagner, Birgit; Alperin, N. (2013): MRI evidence for altered venous drainage and intracranial compliance in mild traumatic brain injury.
In: PLOS ONE 8(2), e55447 [PDF, 1MB]

Lieb, M.; Palm, U.; Chiang, S.; Laubender, Rüdiger P.; Nothdurfter, C.; Sarubin, N.; Mokhtari-Nejad, R.; Koller, G.; Soyka, M. (2013): Pharmacological challenge with naloxone and cue exposure in alcohol dependence: results of a randomized, double-blind placebo-controlled trial. In: World Journal of Biological Psychiatry, Vol. 14, No. 7: pp. 539-546

Modest, D. P.; Camaj, P.; Heinemann, V.; Schwarz, B.; Jung, A.; Laubender, Rüdiger P.; Gamba, S.; Haertl, C.; Stintzing, S.; Primo, S.; Bruns, C. J. (2013): KRAS allel-specific activity of sunitinib in an isogenic disease model of colorectal cancer. In: Journal of Cancer Research and Clinical Oncology, Vol. 139, No. 6: pp. 953-961

Modest, D. P.; Laubender, Rüdiger P.; Stintzing, S.; Giessen, C.; Schulz, C.; Haas, M.; Mansmann, Ulrich; Heinemann, V. (2013): Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: An analysis of the German AIO KRK 0104 trial. In: Acta Oncologica, Vol. 52, No. 5: pp. 956-962

Muehlmann, M.; Koerte, I. K.; Laubender, Rüdiger P.; Steffinger, D.; Lehner, M.; Peraud, A.; Heinen, Florian; Kiefer, M.; Reiser, M.; Ertl-Wagner, Birgit (2013): Magnetic Resonance-Based Estimation of Intracranial Pressure Correlates With Ventriculoperitoneal Shunt Valve Opening Pressure Setting in Children With Hydrocephalus. In: Investigative Radiology, Vol. 48, No. 7: pp. 543-547

Mansmann, Ulrich; Laubender, Rüdiger P. (2013): Methodologic diligence is needed to define and validate tumor-size response metrics to predict overall survival in first-line metastatic colorectal cancer. In: Journal of Clinical Oncology, Vol. 31, No. 34: pp. 4373-4374

Weissenbacher, Tobias; Laubender, Rüdiger P.; Witkin, Steven S.; Gingelmaier, Andrea; Schiessl, Barbara; Kainer, Franziskus; Friese, Klaus; Jeschke, Udo; Dian, Darius; Karl, Katrin (2013): Diagnostic biomarkers of pro-inflammatory immune-mediated preterm birth. In: Archives of Gynecology and Obstetrics, Vol. 287, No. 4: pp. 673-685

Zeiss, K.; Parhofer, K. G.; Heinemann, V.; Haas, M.; Laubender, Rüdiger P.; Holdenrieder, S.; Schulz, C.; Boeck, S. (2013): Glucose and lipid metabolism in patients with advanced pancreatic cancer receiving palliative chemotherapy. In: Anticancer Research, Vol. 33, No. 1: pp. 287-292

Übleis, Christopher; Hellweger, S.; Laubender, Rüdiger P.; Becker, A.; Sohn, H. Y.; Lehner, S.; Haug, A.; Bartenstein, P.; Cumming, P.; van Kriekinge, S. D.; Slomka, P. J.; Hacker, M. (2013): The amount of dysfunctional but viable myocardium predicts long-term survival in patients with ischemic cardiomyopathy and left ventricular dysfunction. In: International Journal of Cardiovascular Imaging, Vol. 29, No. 7: pp. 1645-1653

Übleis, Christopher; Hoyer, X.; van Kriekinge, S. D.; Schuessler, F.; Laubender, Rüdiger P.; Becker, A.; Lehner, S.; Todica, A.; Haug, A.; Bartenstein, P.; Cumming, P.; Germano, G.; Hacker, M. (2013): Association between left ventricular mechanical dyssynchrony with myocardial perfusion and functional parameters in patients with left bundle branch block. In: Journal of Nuclear Cardiology, Vol. 20, No. 2: pp. 253-261

Rochat, M. K.; Laubender, Rüdiger P.; Kuster, D.; Braendli, O.; Moeller, A.; Mansmann, Ulrich; Mutius, Erika von; Wildhaber, J. (2013): Spirometry reference equations for central European populations from school age to old age.
In: PLOS ONE 8(1), e52619 [PDF, 346kB]

Canis, M.; Lechner, A.; Mack, B.; Zengel, P.; Laubender, Rüdiger P.; Koehler, U.; Heissmeyer, V.; Gires, O. (2013): CD133 induces tumour-initiating properties in HEK293 cells. In: Tumor Biology, Vol. 34, No. 1: pp. 437-443

Averbeck, B.; Rucker, F.; Laubender, Rüdiger P.; Carr, R. W. (2013): Thermal grill-evoked sensations of heat correlate with cold pain threshold and are enhanced by menthol and cinnamaldehyde. In: European Journal of Pain, Vol. 17, No. 5: pp. 724-734

Boeck, S.; Jung, A.; Laubender, Rüdiger P.; Neumann, J.; Egg, R.; Goritschan, C.; Ormanns, S.; Haas, M.; Modest, D. P.; Kirchner, T.; Heinemann, V. (2013): KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer. In: Journal of Gastroenterology, Vol. 48, No. 4: pp. 544-548

Boeck, S.; Jung, A.; Laubender, Rüdiger P.; Neumann, J.; Egg, R.; Goritschan, C.; Vehling-Kaiser, U.; Winkelmann, C.; Fischer von Weikersthal, L.; Clemens, M. R.; Gauler, T. C.; Marten, A.; Klein, S.; Kojouharoff, G.; Barner, M.; Geissler, M.; Greten, T. F.; Mansmann, Ulrich; Kirchner, T.; Heinemann, V. (2013): EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104. In: British Journal of Cancer BJC, Vol. 108, No. 2: pp. 469-476

Greif, M.; Ziegler, F. von; Wakili, R.; Tittus, J.; Becker, C.; Helbig, S.; Laubender, Rüdiger P.; Schwarz, W.; D’Anastasi, M.; Schenzle, J.; Leber, A. W.; Becker, A. (2013): Increased pericardial adipose tissue is correlated with atrial fibrillation and left atrial dilatation. In: Clinical Research in Cardiology, Vol. 102, No. 8: pp. 555-562

Giessen, C.; Fischer von Weikersthal, L.; Laubender, Rüdiger P.; Stintzing, S.; Modest, D. P.; Schalhorn, A.; Schulz, C.; Heinemann, V. (2013): Evaluation of prognostic factors in liver-limited metastatic colorectal cancer: a preplanned analysis of the FIRE-1 trial. In: British Journal of Cancer BJC, Vol. 109, No. 6: pp. 1428-1436

Giessen, C.; Graeven, U.; Laubender, Rüdiger P.; Modest, D. P.; Schulz, C.; Porschen, R.; Schmiegel, W.; Reinacher-Schick, A.; Hegewisch-Becker, S.; Stintzing, S.; Heinemann, V. (2013): Prognostic factors for 60-day mortality in first-line treatment of metastatic colorectal cancer (mCRC): individual patient analysis of four randomised, controlled trials by the AIO colorectal cancer study group. In: Annals of Oncology, Vol. 24, No. 12: pp. 3051-3055

Giessen, C.; Laubender, Rüdiger P.; Ankerst, Donna Pauler; Stintzing, S.; Modest, D. P.; Mansmann, Ulrich; Heinemann, V. (2013): Progression-Free Survival as a Surrogate Endpoint for Median Overall Survival in mCRC: Literature-Based Analysis from 50 Randomized First-Line Trials. In: Clinical Cancer Research, Vol. 19, No. 1: pp. 225-235

Giessen, C.; Laubender, Rüdiger P.; Fischer von Weikersthal, L.; Schalhorn, A.; Modest, D. P.; Stintzing, S.; Haas, M.; Mansmann, Ulrich; Heinemann, V. (2013): Early tumor shrinkage in metastatic colorectal cancer: Retrospective analysis from an irinotecan-based randomized first-line trial. In: Cancer Science, Vol. 104, No. 6: pp. 718-724

Haas, M.; Heinemann, V.; Kullmann, F.; Laubender, Rüdiger P.; Klose, C.; Bruns, C. J.; Holdenrieder, S.; Modest, D. P.; Schulz, C.; Boeck, S. (2013): Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy. In: Journal of Cancer Research and Clinical Oncology, Vol. 139, No. 4: pp. 681-689

Heinemann, V.; Ebert, M. P.; Laubender, Rüdiger P.; Bevan, P.; Mala, C.; Boeck, S. (2013): Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer. In: British Journal of Cancer BJC, Vol. 108, No. 4: pp. 766-770

Beigel, Florian; Löhr, Beate; Laubender, Rüdiger P.; Tillack, Cornelia; Schnitzler, Fabian; Breiteneicher, Simone; Weidinger, Maria; Göke, Burkhard; Seiderer, Julia; Ochsenkühn, Thomas; Brand, Stephan (2012): Iron Status and Analysis of Efficacy and Safety of Ferric Carboxymaltose Treatment in Patients with Inflammatory Bowel Disease. In: Digestion, No. 1: pp. 47-54 [PDF, 464kB]

Lehner, S.; Todica, A.; Brunner, S.; Übleis, Christopher; Wang, H.; Wängler, C.; Herbach, N.; Herrler, T.; Böning, G.; Laubender, Rüdiger P.; Cumming, P.; Schirrmacher, R.; Franz, W.; Hacker, M. (2012): Temporal changes in phosphatidylserine expression and glucose metabolism after myocardial infarction: an in vivo imaging study in mice. In: Molecular Imaging, Vol. 11, No. 6: pp. 461-470

Maier, T.; Braun-Falco, M.; Laubender, Rüdiger P.; Ruzicka, T.; Berking, C. (2012): Actinic keratosis in the en-face and slice imaging mode of high-definition optical coherence tomography and comparison with histology. In: British Journal of Dermatology, Vol. 168, No. 1: pp. 120-128

Modest, D. P.; Reinacher-Schick, A.; Stintzing, S.; Giessen, C.; Tannapfel, A.; Laubender, Rüdiger P.; Brodowicz, T.; Knittelfelder, R.; Vrbanec, D.; Schmiegel, W.; Heinemann, V.; Zielinski, C. C. (2012): Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D-mutated metastatic colorectal cancer: a pooled analysis. In: Anticancer Drugs, Vol. 23, No. 6: pp. 666-673

Modest, D. P.; Jung, A.; Moosmann, N.; Laubender, Rüdiger P.; Giessen, C.; Schulz, C.; Haas, M.; Neumann, J.; Boeck, S.; Kirchner, T.; Heinemann, V.; Stintzing, S. (2012): The influence of KRAS- and BRAF-mutations on the efficacy of cetuximab-based 1st-line therapy of metastatic colorectal cancer: An analysis of the AIO KRK-0104 -trial. In: International Journal of Cancer, Vol. 131, No. 4: pp. 980-986

Maier, T.; Laubender, Rüdiger P.; Sturm, R. A.; Klingenstein, A.; Korting, H. C.; Ruzicka, T.; Berking, C. (2012): Osteopontin expression in plasma of melanoma patients and in melanocytic tumours. In: Journal of the European Academy of Dermatology and Venereology, Vol. 26, No. 9: pp. 1084-1091

Weissenbacher, Tobias; Laubender, Rüdiger P.; Witkin, Steven S.; Gingelmaier, Andrea; Schiessl, Barbara; Kainer, Franziskus; Friese, Klaus; Jeschke, Udo; Dian, Darius; Karl, Katrin (2012): Influence of maternal age, gestational age and fetal gender on expression of immune mediators in amniotic fluid. In: BMC Research Notes, Vol. 5, No. 1: p. 375

Übleis, Christopher; Hellweger, S.; Laubender, Rüdiger P.; Becker, A.; Sohn, H. Y.; Lehner, S.; Haug, A.; Bartenstein, P.; Cumming, P.; van Kriekinge, S. D.; Slomka, P. J.; Hacker, M. (2012): Left ventricular dyssynchrony assessed by gated SPECT phase analysis is an independent predictor of death in patients with advanced coronary artery disease and reduced left ventricular function not undergoing cardiac resynchronization therapy. In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, No. 10: pp. 1561-1569

Schäfer, C.; Seeliger, H.; Bader, D. C.; Assmann, G.; Buchner, D.; Guo, Y.; Ziesch, A.; Palagyi, A.; Ochs, S.; Laubender, Rüdiger P.; Jung, A.; de Toni, E. N.; Kirchner, T.; Göke, Burkhard; Bruns, C.; Gallmeier, E. (2012): Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma. In: Journal of Cellular and Molecular Medicine, Vol. 16, No. 8: pp. 1776-1791

Connell, L.; Koerte, I. K.; Laubender, Rüdiger P.; Morhard, D.; Linn, J.; Becker, H. C.; Reiser, M.; Brueckmann, H.; Ertl-Wagner, Birgit (2012): Hyperdense basilar artery sign-a reliable sign of basilar artery occlusion. In: Neuroradiology, Vol. 54, No. 4: pp. 321-327

Ertl-Wagner, Birgit; Koerte, Inga; Kümpfel, Tania; Blaschek, Astrid; Laubender, Rüdiger P.; Schick, Max; Steffinger, Denise; Kaufmann, David; Heinen, Florian; Reiser, Maximilian; Alperin, Noam; Hohlfeld, Reinhard (2012): Non-specific alterations of craniocervical venous drainage in multiple sclerosis revealed by cardiac-gated phase-contrast MRI. In: Multiple Sclerosis, Vol. 18, No. 7: pp. 1000-1007

Hofheinz, R. D.; Heinemann, V.; Fischer von Weikersthal, L.; Laubender, Rüdiger P.; Gencer, D.; Burkholder, I.; Hochhaus, A.; Stintzing, S. (2012): Capecitabine-associated hand-foot-skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer. In: British Journal of Cancer BJC, Vol. 107, No. 10: pp. 1678-1683

Grunke, M.; Witt, M. N.; Ronneberger, M.; Schnez, A.; Laubender, Rüdiger P.; Engelbrecht, M.; Kavanaugh, A.; Schulze-Koops, H. (2012): Use of the 28-Joint Count Yields Significantly Higher Concordance Between Different Examiners Than the 66/68-Joint Count. In: Journal of Rheumatology, Vol. 39, No. 7: pp. 1334-1340

Freydanck, M. K.; Laubender, Rüdiger P.; Rack, B.; Schuhmacher, L.; Jeschke, Udo; Scholz, C. (2012): Two-marker Combinations for Preoperative Discrimination of Benign and Malignant Ovarian Masses. In: Anticancer Research, Vol. 32, No. 5: pp. 2003-2008

Haas, M.; Laubender, Rüdiger P.; Klose, C.; Schulz, C.; Mansmann, Ulrich; Boeck, S.; Heinemann, V. (2012): External Validation of 2 Prognostic Indices for Patients With Advanced Pancreatic Cancer Treated With First-line Therapy. In: Pancreas, Vol. 41, No. 5: pp. 738-744

Modest, D. P.; Stintzing, S.; Laubender, Rüdiger P.; Neumann, J.; Jung, A.; Giessen, C.; Haas, M.; Aubele, P.; Schulz, C.; Boeck, S.; Stemmler, H. J.; Kirchner, T.; Heinemann, V. (2011): Clinical characterization of patients with metastatic colorectal cancer depending on the KRAS status. In: Anticancer Drugs, Vol. 22, No. 9: pp. 913-918

Stallhofer, J.; Denk, G. U.; Glas, J.; Laubender, Rüdiger P.; Göke, Burkhard; Rust, C.; Brand, S.; Pusl, T. (2011): Analysis of IL2/IL21 Gene Variants in Cholestatic Liver Diseases Reveals an Association with Primary Sclerosing Cholangitis. In: Digestion, Vol. 84, No. 1: pp. 29-35

Zitzmann, K.; de Toni, E.; Ruden, J. von; Brand, S.; Göke, Burkhard; Laubender, Rüdiger P.; Auernhammer, C. J. (2011): The novel Raf inhibitor Raf265 decreases Bcl-2 levels and confers TRAIL-sensitivity to neuroendocrine tumour cells. In: Endocrine-Related Cancer, Vol. 18, No. 2: pp. 277-285

Koerte, I. K.; Schankin, C. J.; Immler, S.; Lee, S.; Laubender, Rüdiger P.; Grosse, C.; Eftimov, L.; Milde-Busch, A.; Reiser, M.; Straube, A.; Heinen, Florian; Alperin, N.; Ertl-Wagner, Birgit (2011): Altered Cerebrovenous Drainage in Patients With Migraine as Assessed by Phase-Contrast Magnetic Resonance Imaging. In: Investigative Radiology, Vol. 46, No. 7: pp. 434-440

Koerte, Inga; Pelavin, Paula; Kirmess, Berit; Fuchs, Teresa; Berweck, Steffen; Laubender, Rüdiger P.; Borggraefe, Ingo; Schroeder, Sebastian; Danek, Adrian; Rummeny, Claudia; Reiser, Maximilian; Kubicki, Marek; Shenton, Martha E.; Ertl-Wagner, Birgit; Heinen, Florian (2011): Anisotropy of transcallosal motor fibres indicates functional impairment in children with periventricular leukomalacia. In: Developmental medicine and child neurology, Vol. 53, No. 2: pp. 179-186

Giessen, C.; Stintzing, S.; Laubender, Rüdiger P.; Ankerst, Donna Pauler; Schulz, C.; Moosmann, N.; Modest, D. P.; Schalhorn, A.; Fischer von Weikersthal, L.; Heinemann, V. (2011): Analysis for Prognostic Factors of 60-day Mortality: Evaluation of an Irinotecan-Based Phase III Trial Performed in the First-Line Treatment of Metastatic Colorectal Cancer. In: Clinical Colorectal Cancer, Vol. 10, No. 4: pp. 317-324

Glas, Jürgen; Seiderer, Julia; Tillack, Cornelia; Pfennig, Simone; Beigel, Florian; Jürgens, Matthias; Olszak, Torsten; Laubender, Rüdiger P.; Weidinger, Maria; Müller-Myhsok, Bertram; Göke, Burkhard; Ochsenkühn, Thomas; Lohse, Peter; Diegelmann, Julia; Czamara, Darina; Brand, Stephan (2010): The NOD2 single nucleotide polymorphisms rs2066843 and rs2076756 are novel and common Crohn's disease susceptibility gene variants.
In: PLOS ONE 5(12), e14466 [PDF, 125kB]

Bleiziffer, Sabine; Ali, Ayyaz; Hettich, Ina M.; Akdere, Deniz; Laubender, Rüdiger P.; Ruzicka, Daniel; Boehm, Johannes; Lange, Ruediger; Eichinger, Walter (2010): Impact of the indexed effective orifice area on mid-term cardiac-related mortality after aortic valve replacement. In: Heart, Vol. 96, No. 11: pp. 865-871 [PDF, 388kB]

Laubender, Rüdiger P.; Bender, R. (2010): Estimating adjusted risk difference (RD) and number needed to treat (NNT) measures in the Cox regression model. In: Statistics in Medicine, Vol. 29, No. 7-8: pp. 851-859

Boeck, S.; Haas, M.; Laubender, Rüdiger P.; Kullmann, F.; Klose, C.; Bruns, C. J.; Wilkowski, R.; Stieber, P.; Holdenrieder, S.; Buchner, Hannes; Mansmann, Ulrich; Heinemann, V. (2010): Application of a time-varying covariate model to the analysis of CA 19-9 as serum biomarker in patients with advanced pancreatic cancer. In: Clinical Cancer Research, Vol. 16, No. 3: pp. 986-994

Horster, S.; Laubender, Rüdiger P.; Lehmeyer, L.; Ankerst, Donna Pauler; Eberle, J.; Reinert, R.; Imohl, M.; van der Linden, M.; Schweiger, B.; Bogner, J. R. (2010): Influence of antiretroviral therapy on immunogenicity of simultaneous vaccinations against influenza, pneumococcal disease and hepatitis A and B in human immunodeficiency virus positive individuals. In: Journal of Infection, Vol. 61, No. 6: pp. 484-491

Koerte, I.; Eftimov, L.; Laubender, Rüdiger P.; Esslinger, O.; Schroeder, A. S.; Ertl-Wagner, Birgit; Wahllaender-Danek, U.; Heinen, Florian; Danek, Adrian (2010): Mirror movements in healthy humans across the lifespan: effects of development and ageing. In: Developmental Medicine & Child Neurology, Vol. 52, No. 12: pp. 1106-1112

Jürgens, Matthias; Brand, S.; Laubender, Rüdiger P.; Seiderer, Julia; Glas, Jürgen; Wetzke, M.; Wagner, J.; Pfennig, S.; Tillack, C.; Beigel, Florian; Weidinger, M.; Schnitzler, Fabian; Kreis, M. E.; Göke, Burkhard; Lohse, P.; Herrmann, K.; Ochsenkühn, Thomas (2010): The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn’s disease independent of the IL23R genotype. In: Journal of Gastroenterology, Vol. 45, No. 7: pp. 721-731

Jürgens, Matthias; Laubender, Rüdiger P.; Hartl, F.; Weidinger, M.; Seiderer, Julia; Wagner, J.; Wetzke, M.; Beigel, Florian; Pfennig, S.; Stallhofer, J.; Schnitzler, Fabian; Tillack, Cornelia; Lohse, Peter; Göke, Burkhard; Glas, Jürgen; Ochsenkühn, Thomas; Brand, Stephan (2010): Disease Activity, ANCA, and IL23R Genotype Status Determine Early Response to Infliximab in Patients With Ulcerative Colitis. In: American Journal of Gastroenterology, Vol. 105, No. 8: pp. 1811-1819

Haas, M.; Laubender, Rüdiger P.; Stieber, P.; Holdenrieder, S.; Bruns, C. J.; Wilkowski, R.; Mansmann, Ulrich; Heinemann, V.; Boeck, S. (2010): Prognostic relevance of CA 19-9, CEA, CRP, and LDH kinetics in patients treated with palliative second-line therapy for advanced pancreatic cancer. In: Tumor Biology, Vol. 31, No. 4: pp. 351-357

Lehrke, Michael; Greif, Martin; Broedl, Uli C.; Lebherz, Corinna; Laubender, Rüdiger P.; Becker, Alexander; Ziegler, Franz von; Tittus, Janine; Reiser, Maximilian; Becker, Christoph; Göke, Burkhard; Steinbeck, Gerhard; Leber, Alexander W.; Parhofer, Klaus G.: MMP-1 serum levels predict coronary atherosclerosis in humans. In: Cardiovascular Diabetology 2009, 8:50 [PDF, 308kB]

Lehrke, M.; Becker, A.; Greif, M.; Stark, R.; Laubender, Rüdiger P.; Ziegler, F. von; Lebherz, C.; Tittus, J.; Reiser, M.; Becker, C.; Göke, Burkhard; Leber, A.; Parhofer, K. G.; Broedl, U. C. (2009): Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. In: European Journal of Endocrinology, Vol. 161, No. 2: pp. 339-344

Sing, A.; Schmoldt, S.; Laubender, Rüdiger P.; Heesemann, J.; Sing, D.; Wildner, M. (2009): Seasonal variation of Pneumocystis jirovecii infection: analysis of underlying climatic factors. In: Clinical Microbiology and Infection, Vol. 15, No. 10: pp. 957-960

Koerte, I.; Heinen, Florian; Fuchs, T.; Laubender, Rüdiger P.; Pomschar, A.; Stahl, R.; Berweck, S.; Winkler, P.; Hufschmidt, A.; Reiser, M. F.; Ertl-Wagner, Birgit (2009): Anisotropy of callosal motor fibers in combination with transcranial magnetic stimulation in the course of motor development. In: Investigative Radiology, Vol. 44, No. 5: pp. 279-284

Paper

Laubender, Rüdiger P.; Mansmann, Ulrich (24. December 2014): Estimating individual treatment effects from responses and a predictive biomarker in a parallel group RCT. Department of Statistics: Technical Reports, No.176 [PDF, 2MB]

This list was generated on Thu Jun 20 04:53:06 2019 CEST.